CoreCap Advisors’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8 Hold
4
﹤0.01% 3159
2026
Q1
$9 Hold
4
﹤0.01% 2918
2025
Q4
$13 Hold
4
﹤0.01% 2933
2025
Q3
$10 Hold
4
﹤0.01% 2776
2025
Q2
$13 Hold
4
﹤0.01% 2737
2025
Q1
$17 Hold
4
﹤0.01% 3113
2024
Q4
$19 Hold
4
﹤0.01% 2820
2024
Q3
$15 Buy
+4
New +$14 ﹤0.01% 2607
2024
Q2
Sell
-4
Closed -$19 2312
2024
Q1
$19 Buy
+4
New +$23 ﹤0.01% 2497
2022
Q4
$1.84K Buy
+104
New +$2.07K ﹤0.01% 1950
2022
Q3
Sell
-104
Closed -$2K 1629
2022
Q2
$2K Buy
+104
New +$2.32K ﹤0.01% 1893
2022
Q1
Sell
-400
Closed -$10K 1626
2021
Q4
$10K Buy
+400
New +$11.1K ﹤0.01% 1551

Other funds holding PETS

CoreCap Advisors's PETS Position: Q2 2026 in Review

CoreCap Advisors held its PetMed Express (PETS) position steady in Q2 2026 at 4 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #3159.

CoreCap Advisors first reported a position in PETS in Q4 2021 and has held it in 12 quarters since. The position peaked at $10K in Q4 2021. 6 funds tracked by Wall St. Rank hold PETS as of Q2 2026.

  • CoreCap Advisors held 4 shares of PetMed Express worth $8 as of Q2 2026.
  • CoreCap Advisors left its PetMed Express share count unchanged in Q2 2026.
  • PetMed Express made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #3159 holding.
  • CoreCap Advisors first reported a position in PetMed Express in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's PetMed Express position peaked at $10K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held PetMed Express as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.